Search

everythinglearnresearchcommunity

for

Search:↓

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

Using 5α-reductase inhibitors for hair loss can cause lasting sexual, physical, mental, and vascular health issues in men, even after stopping the medication.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Both drugs lower DHT levels, with GI198745 being more effective.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Taking 5α-reductase inhibitors does not significantly increase the risk of breast cancer in men.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Certain drugs change freshwater snail shells to a "banana" shape.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

5α-reductase inhibitors can cause serious and possibly lasting sexual and psychological side effects.

Using 5-alpha reductase inhibitors may lower the risk of breast cancer in females.

Women also use 5α-reductase inhibitors, and their effects differ from men.

Certain drugs that block specific enzymes can help treat prostate diseases.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

The review suggests younger men taking 1 mg finasteride report more side effects, including sexual, skin, metabolic, and psychological issues.

Dutasteride works better than finasteride for hair loss, with both being safe to use.

Taking 5-Alpha Reductase Inhibitors before bladder removal surgery might make high-grade bladder tumors less aggressive.

Starting 5-alpha reductase inhibitors does not significantly increase the risk of rhabdomyolysis in older men, but is linked to a higher risk of muscle conditions.